• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·UK·Healthcare·DOC.AX
Share

Doctor Care Anywhere Group PLC Stocks

A$ 0.13Last Updated 09.10.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

A$ 33.16M

A$ 0.13
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom and the Republic of Ireland. It offers services in the areas of medical letters, imaging support, blood testing, and mental health support, as well as comprehensive health assessments, health solutions, specialist care pathways, physiotherapy support, and GP and ACP appointments. The company provides treatments for allergies, intolerances, colds, flu, minor illnesses, gut health, joint, muscles, lifestyle support, men’s and women’s health, mental health, sexual health, and skin conditions. Doctor Care Anywhere Group PLC was founded in 2013 and is headquartered in Mayfair, the United Kingdom.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Very favourable
7/7

The average target price of DOC.AX is 0.22 and suggests 86.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.10.2026 15:28

Morning in New York: A New Stress Test for the AI Rally

09.10.2026 15:17

With AI, it's possible to develop a drug twice as fast. Which companies is Cathie Wood betting on?

09.10.2026 15:00

TRex Bio IPO: Shares of Eli Lilly's Partner Pharmaceutical Company Are Now Available

09.10.2026 14:39

European telecom stocks plummeted following the U.S. market: SpaceX is entering the mobile carrier market

09.10.2026 13:23

What makes Physical Intelligence—the company Bezos has invested in—so interesting?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026